Current concepts in the treatment of epidermolysis bullosa acquisita

Bibliography

• Woodley DT, Briggaman RA, O'Keefe EJ, Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984;310(16):1007-13
   Google Scholar
• Woodley DT, Chang C, Saadat P, Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005;124(5):958-64
   Google Scholar
• Ishii N, Yoshida M, Hisamatsu Y, Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol 2004;150(5):843-51
   Google Scholar
• Schmidt E, Hopfner B, Chen M, Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol 2002;147(3):592-7
   Google Scholar
• Bernard P, Vaillant L, Labeille B, Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 1995;131(1):48-52
   Google Scholar
• Gammon WR, Heise ER, Burke WA, Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 1988;91(3):228-32
   Google Scholar
• Remington J, Chen M, Burnett J, Woodley DT. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Curr Dir Autoimmun 2008;10:195-205
   Google Scholar
• Woodley DT, O'Keefe EJ, Reese MJ, Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. J Invest Dermatol 1986;86(6):668-72
   Google Scholar
• Chen M, Chan LS, Cai X, Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 1997;108(1):68-72
   Google Scholar
• Wozniak K, Kazama T, Kowalewski C. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy. Arch Dermatol 2003;139(8):1007-11
   Google Scholar
• Lehman JS, Camilleri MJ, Gibson LE. Epidermolysis bullosa acquisita: concise review and practical considerations. Int J Dermatol 2009;48(3):227-35, quiz 235-6
   Google Scholar
• Engineer L, Ahmed AR. Emerging treatment for epidermolysis bullosa acquisita. J Am Acad Dermatol 2001;44(5):818-28
   Google Scholar
• Wojnarowska F, Kirtschig G, Khumalo N. Treatment of subepidermal immunobullous diseases. Clin Dermatol 2001;19(6):768-77
   Google Scholar
• Kirtschig G, Murrell D, Wojnarowska F, Khumalo N. Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database Syst Rev 2003;(1):CD004056
   Google Scholar
• Purdy MJ, Fairbrother GE. Case report: epidermolysis bullosa acquisita. Australas J Dermatol 1972;13(1):27-30
   Google Scholar
• Borok M, Heng MC, Ahmed AR. Epidermolysis bullosa acquisita in an 8-year-old girl. Pediatr Dermatol 1986;3(4):315-22
   Google Scholar
• Rubenstein R, Esterly NB, Fine JD. Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl. Arch Dermatol 1987;123(6):772-6
   Google Scholar
• McCuaig CC, Chan LS, Woodley DT, Epidermolysis bullosa acquisita in childhood. Differentiation from hereditary epidermolysis bullosa. Arch Dermatol 1989;125(7):944-9
   Google Scholar
• Arpey CJ, Elewski BE, Moritz DK, Gammon WR. Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature. J Am Acad Dermatol 1991;24(5 Pt 1):706-14
   Google Scholar
• Inauen P, Hunziker T, Gerber H, Childhood epidermolysis bullosa acquisita. Br J Dermatol 1994;131(6):898-900
   Google Scholar
• Lacour JP, Bernard P, Rostain G, Childhood acquired epidermolysis bullosa. Pediatr Dermatol 1995;12(1):16-20
   Google Scholar
• Park SB, Cho KH, Youn JL, Epidermolysis bullosa acquisita in childhood–a case mimicking chronic bullous dermatosis of childhood. Clin Exp Dermatol 1997;22(5):220-2
   Google Scholar
• Callot-Mellot C, Bodemer C, Caux F, Epidermolysis bullosa acquisita in childhood. Arch Dermatol 1997;133(9):1122-6
   Google Scholar
• Taniuchi K, Inaoki M, Nishimura Y, Nonscarring inflammatory epidermolysis bullosa acquisita with esophageal involvement and linear IgG deposits. J Am Acad Dermatol 1997;36(2 Pt 2):320-2
   Google Scholar
• Hayashi K, Ueda M, Sakai M, Epidermolysis bullosa acquisita in a 6-year-old Japanese boy. Int J Dermatol 1998;37(8):612-14
   Google Scholar
• Su JC, Varigos GA, Dowling J. Epidermolysis bullosa acquisita in childhood. Australas J Dermatol 1998;39(1):38-41
   Google Scholar
• Hughes AP, Callen JP. Epidermolysis bullosa acquisita responsive to dapsone therapy. J Cutan Med Surg 2001;5(5):397-9
   Google Scholar
• Wu JJ, Wagner AM. Epidermolysis bullosa acquisita in an 8-year-old girl. Pediatr Dermatol 2002;19(4):368-71
   Google Scholar
• Schmidt E, Hopfner B, Chen M, Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol 2002;147(3):592-7
   Google Scholar
• Madan V, Jamieson LA, Bhogal BS, Wong CS. Inflammatory epidermolysis bullosa acquisita mimicking toxic epidermal necrolysis and dermatitis herpetiformis. Clin Exp Dermatol 2009;34(8):e705-8
   Google Scholar
• Howard T, Brunner WC. Epidermolysis bullosa acquisita in an 18-year-old African-American male: a case report. S D Med 2009;62(2):50-1
   Google Scholar
• Megahed M, Scharffetter-Kochanek K. Epidermolysis bullosa acquisita–successful treatment with colchicine. Arch Dermatol Res 1994;286(1):35-46
   Google Scholar
• Cunningham BB, Kirchmann TT, Woodley D. Colchicine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1996;34(5 Pt 1):781-4
   Google Scholar
• Dantas PE, Nishiwaki-Dantas MC, Seguim MH, Cursino JW. Bilateral corneal involvement in epidermolysis bullosa acquisita. Cornea 2001;20(6):664-7
   Google Scholar
• Arora KP, Sachdeva B, Singh N, Bhattacharya SN. Remission of recalcitrant epidermolysis bullosa acquisita (EBA) with colchicine monotherapy. J Dermatol 2005;32(2):114-19
   Google Scholar
• Tanaka N, Dainichi T, Ohyama B, A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine. J Am Acad Dermatol 2009;61(4):715-19
   Google Scholar
• Robinowitz BN, Towery DS, Meyers SW, Successful treatment of epidermolysis bullosa acquisita with mesalazine. Br J Dermatol 1997;137(1):154-5
   Google Scholar
• Zachariae H. Cyclosporine A in epidermolysis bullosa acquisita. J Am Acad Dermatol 1987;17(6):1058-9
   Google Scholar
• Crow LL, Finkle JP, Gammon WR, Woodley DT. Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 1988;19(5 Pt 2):937-42
   Google Scholar
• Gupta AK, Ellis CN, Nickoloff BJ, Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol 1990;126(3):339-50
   Google Scholar
• Merle C, Blanc D, Zultak M, Intractable epidermolysis bullosa acquisita: efficacy of cyclosporin A. Dermatologica 1990;181(1):44-7
   Google Scholar
• Layton AM, Cunliffe WJ. Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 1990;22(3):535-6
   Google Scholar
• Klein JS, Goldin HM, Keegan C, Clear-cell carcinoma of the lung in a patient treated with cyclosporine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1991;24(2 Pt 1):297
   Google Scholar
• Burger J, Gmur J, Bruckner-Tuderman L. Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation? Bone Marrow Transplant 1992;9(2):139-41
   Google Scholar
• Clement M, Ratnesar P, Thirumoorthy T, Epidermolysis bullosa acquisita–a case with upper airways obstruction requiring tracheostomy and responding to cyclosporin. Clin Exp Dermatol 1993;18(6):548-51
   Google Scholar
• Khatri ML, Benghazeil M, Shafi M. Epidermolysis bullosa acquisita responsive to cyclosporin therapy. J Eur Acad Dermatol Venereol 2001;15(2):182-4
   Google Scholar
• Maize JC Jr, Cohen JB. Cyclosporine controls epidermolysis bullosa acquisita co-occurring with acquired factor VIII deficiency. Int J Dermatol 2005;44(8):692-4
   Google Scholar
• Schattenkirchner S, Eming S, Hunzelmann N, Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting. Br J Dermatol 1999;141(5):932-3
   Google Scholar
• Kowalzick L, Suckow S, Ziegler H, Mycophenolate mofetil in epidermolysis bullosa acquisita. Dermatology 2003;207(3):332-4
   Google Scholar
• Marzano AV, Dassoni F, Caputo R. Treatment of refractory blistering autoimmune diseases with mycophenolic acid. J Dermatolog Treat 2006;17(6):370-6
   PubMed Web of Science ®Google Scholar
• Meier F, Sonnichsen K, Schaumburg-Lever G, Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins. J Am Acad Dermatol 1993;29(2 Pt 2):334-7
   Google Scholar
• Caldwell JB, Yancey KB, Engler RJ, James WD. Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins. J Am Acad Dermatol 1994;31(5 Pt 1):827-8
   Google Scholar
• Mohr C, Sunderkotter C, Hildebrand A, Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins. Br J Dermatol 1995;132(5):824-6
   Google Scholar
• Kofler H, Wambacher-Gasser B, Topar G, Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita. J Am Acad Dermatol 1997;36(2 Pt 2):331-5
   Google Scholar
• Harman KE, Whittam LR, Wakelin SH, Black MM. Severe, refractory epidermolysis bullosa acquisita complicated by an oesophageal stricture responding to intravenous immune globulin. Br J Dermatol 1998;139(6):1126-7
   Google Scholar
• Harman KE, Black MM. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Br J Dermatol 1999;140(5):865-74
   Google Scholar
• Jappe U, Zillikens D, Bonnekoh B, Gollnick H. Epidermolysis bullosa acquisita with ultraviolet radiationsensitivity. Br J Dermatol 2000;142(3):517-20
   Google Scholar
• Gourgiotou K, Exadaktylou D, Aroni K, Epidermolysis bullosa acquisita: treatment with intravenous immunoglobulins. J Eur Acad Dermatol Venereol 2002;16(1):77-80
   Google Scholar
• Engineer L, Dow EC, Braverman IM, Ahmed AR. Epidermolysis bullosa acquisita and multiple myeloma. J Am Acad Dermatol 2002;47(6):943-6
   Google Scholar
• Campos M, Silvente C, Lecona M, Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin. Clin Exp Dermatol 2006;31(1):71-3
   Google Scholar
• Letko E, Bhol K, Anzaar F, Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita. Arch Ophthalmol 2006;124(11):1615-18
   PubMedGoogle Scholar
• Segura S, Iranzo P, Martinez-de Pablo I, High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases. J Am Acad Dermatol 2007;56(6):960-7
   Google Scholar
• Tayal U, Burton J, Dash C, Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita. Clin Immunol 2008;129(3):518-19
   Google Scholar
• Schmidt E, Benoit S, Brocker EB, Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab. Arch Dermatol 2006;142(2):147-50
   Google Scholar
• Sadler E, Schafleitner B, Lanschuetzer C, Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab. Br J Dermatol 2007;157(2):417-19
   Google Scholar
• Niedermeier A, Eming R, Pfutze M, Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies). Arch Dermatol 2007;143(2):192-8
   Google Scholar
• Wallet-Faber N, Franck N, Batteux F, Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab. Dermatology 2007;215(3):252-5
   Google Scholar
• Crichlow SM, Mortimer NJ, Harman KE. A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita. Br J Dermatol 2007;156(1):194-6
   Google Scholar
• Mercader P, Rodenas JM, Pena A, Mascaro JM Jr. Fatal Pseudomona pneumonia following rituximab therapy in a patient with epidermolysis bullosa acquisita. J Eur Acad Dermatol Venereol 2007;21(8):1141-2
   Google Scholar
• Egan CA, Brown M, White JD, Yancey KB. Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab. Clin Immunol 2001;101(2):146-51
   Google Scholar
• Miller JL, Stricklin GP, Fine JD, Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy. Br J Dermatol 1995;133(3):467-71
   Google Scholar
• Gordon KB, Chan LS, Woodley DT. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy. Br J Dermatol 1997;136(3):415-20
   Google Scholar
• Furue M, Iwata M, Yoon HI, Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer. J Am Acad Dermatol 1986;14(5 Pt 2):873-8
   Google Scholar
• Buell C, Koo J. Long-term safety of mycophenolate mofetil and cyclosporine: a review. J Drugs Dermatol 2008;7(8):741-8
   Google Scholar